biospatial
biospatial is a healthcare analytics company that aggregates EMS electronic patient care reports from 40+ US states using proprietary AI and machine learning, serving state EMS agencies, federal health authorities, hospital systems, and behavioral health organizations with syndromic surveillance and prehospital intelligence.
- Company typePrivate
- Founded2017
- HeadquartersDurham, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What biospatial does
biospatial is a healthcare analytics company that aggregates and analyzes electronic patient care reports (ePCRs) generated by Emergency Medical Services (EMS) providers, applying proprietary AI and machine learning to surface near real-time public health, operational, and clinical insights. Founded in 2017 in Durham, NC, the company has built a national prehospital data repository spanning 40+ US states and 28 partner state EMS offices, totaling over 130 million ePCRs and processing more than 100,000 new records daily. The platform is NEMSIS v3 and v3.5 compliant and supports syndromic surveillance, opioid and overdose tracking, COVID-19 monitoring, automotive safety, disaster response, and clinical trial feasibility use cases. Product offerings include the NEMSIS Data Repository, Patient Registry, biospatial Navigate for Hospitals and Health Systems, and biospatial Discover for Behavioral Health.
biospatial firmographics
Firmographics- Name
- biospatial
- Legal name
- biospatial, Inc.
- Website
- https://biospatial.io
- Company type
- Private
- Founded year
- 2017
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- biospatial is a healthcare analytics company that aggregates EMS electronic patient care reports from 40+ US states using proprietary AI and machine learning, serving state EMS agencies, federal health authorities, hospital systems, and behavioral health organizations with syndromic surveillance and prehospital intelligence.
- Ownership category
- akta.pro rank
Where biospatial is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
biospatial business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Data Analytics Platform Subscription: biospatial provides its analytics platform to state EMS offices, federal agencies, hospital systems, and commercial healthcare entities. Data owners (state EMS offices) receive access to data visualization tools, syndromic surveillance, dashboards, and clinical/operational reporting at no cost. Commercial entities pay for access to the platform's analytics and market intelligence capabilities.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
biospatial product offering
Product offeringCore offering
biospatial combines EMS electronic patient care reports (ePCR) from thousands of EMS providers with other electronic healthcare data sources using proprietary AI and machine learning to deliver near real-time analytics, syndromic surveillance, and market intelligence. It offers a Patient Registry for cross-continuum outcome tracking, the NEMSIS Data Repository, biospatial Navigate for Hospitals, and biospatial Discover for Behavioral Health to public-sector agencies and commercial healthcare organizations.
Product overview
Biospatial is a healthcare analytics platform that operates as a unified platform with integrated modules. The core platform combines EMS electronic patient care reports (ePCRs) from thousands of providers across 40+ US states with other electronic healthcare data sources using proprietary AI and machine learning. Key products include the Patient Registry for patient tracking and hospital integration, and the NEMSIS Data Repository providing real-time access to EMS data with over 100,000 new records processed daily. Additional modules include Navigate for Hospitals and Health Systems (strategic market intelligence) and Discover for Behavioral Health (crisis response analytics). The platform supports EMS, hospital, federal government, and behavioral health customer segments with capabilities spanning syndromic surveillance, opioid tracking, COVID-19 monitoring, automotive safety, and disaster response. Biospatial was acquired by ImageTrend in January 2025.
Differentiator
Problem solved
Functional benefit
Brands
- Patient Registry: Patient tracking and EMS data integration with hospital records
- NEMSIS Data Repository
- biospatial Analytics
- biospatial Navigate for Hospitals and Health Systems
- biospatial Discover for Behavioral Health
Products and services
- Patient Registry Patient Registry is biospatial's product for tracking patients across the healthcare continuum. It uses the company's proprietary data linking capabilities to connect EMS patient encounters with downstream healthcare outcomes, enabling longitudinal patient tracking for public health agencies, hospitals, and behavioral health operators.
- NEMSIS Data Repository NEMSIS Data Repository is biospatial's national EMS data repository, NEMSIS v3 and v3.5 compliant, covering tens of thousands of EMS providers across more than 40 U.S. states. It serves as the foundational data asset that powers biospatial's syndromic surveillance, dashboards, and market intelligence analytics products.
- biospatial Navigate for Hospitals biospatial Navigate for Hospitals is a market intelligence product purpose-built for hospital and health system customers. It leverages biospatial's linked EMS and healthcare data to deliver prehospital volume trends, patient origin and destination insights, competitive benchmarking, and EMS market assessment that inform hospital strategy, growth, and operational planning.
- biospatial Discover for Behavioral Health biospatial Discover for Behavioral Health is an analytics product designed for behavioral health centers and operators. It applies biospatial's linked EMS and behavioral health encounter data to support clinical and operational decision-making, including analysis of prehospital interactions involving mental health and substance use populations, and tracking outcomes across the behavioral health care continuum.
Quantifiable outcome
- EMS data captures 1.8 times more monthly opioid-involved overdose encounters than emergency department data (CDC study)
- +3 more outcomes
Companies that use biospatial
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
biospatial technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature8 records
biospatial partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- ImageTrendcoreImageTrend, based in Lakeville, MN, acquired biospatial in January 2025 for an undisclosed amount. The acquisition integrates biospatial's electronic patient care reports with ImageTrend's incident data analytics to enhance community health and safety insights. ImageTrend collects 80% of U.S. incident data and serves over 3,000 customers across Fire, EMS, and Hospital segments. biospatial now operates as 'biospatial by ImageTrend'.
- District of Columbia Department of Health (DC Health)coreDC Health completed Data Use and Analytics agreements to become the 28th state EMS office to partner with biospatial. DC Health submits NEMSIS ePCRs to the biospatial platform to assist in national preparedness and enhance DC's ability to visualize its data with other relevant data layers.
- National EMS Quality Alliance (NEMSQA)corebiospatial entered into a partnership with NEMSQA to support the development of evidence-based quality measures for emergency medical services. biospatial serves as a Bronze Corporate Partner and its platform computes and tracks over 150 EMS quality and performance measures, including the 21 National EMS Quality Alliance Measures. The partnership aims to advance EMS data quality and empower EMS stakeholders with data-driven insights to improve patient care.
- InterveXion Therapeutics and Syneos Healthminorbiospatial conducted a case study with InterveXion Therapeutics and Syneos Health, using biospatial data for clinical trial feasibility and site identification for a substance abuse study.
- Centers for Disease Control and Prevention (CDC)coreCDC contracted biospatial to provide near real-time syndromic surveillance utilizing EMS data. biospatial contributed aggregate data to a CDC research paper published in ScienceDirect on opioid overdose trends, comparing EMS and emergency department data across nine states from 2020-2022.
- Maine EMScoreMaine EMS became the 23rd state to partner with biospatial, submitting de-identified NEMSIS data elements to the platform to assist in national preparedness and enhance Maine's ability to visualize its data with other data layers.
- Colorado Department of Public Health and Environment (CDPHE)coreCDPHE became the 22nd state to partner with biospatial, enabling syndromic surveillance of topic areas including suicide, overdoses, and traffic crashes, and EMS agency performance benchmarking.
- California Emergency Medical Services Authority (EMSA)coreCalifornia EMSA became the 21st state to partner with biospatial in Fall 2019, enabling the state to use existing EMS data to deliver timely actionable information analyses at no cost to the State.
- Rhode Island Department of HealthcoreRhode Island Department of Health, an early partner since June 2017, used the biospatial platform to identify gaps in bystander CPR rates, leading to targeted community training initiatives. The state has been active in developing syndromes and performance measures on the platform.
- National Association of State EMS Officials (NASEMSO)coreNASEMSO has partnered with biospatial because of the value analytics can provide to the NEMSIS data that state EMS offices collect. biospatial is a Platinum sponsor of NASEMSO and regularly presents at annual meetings, working directly with State EMS Directors, Medical Directors, and Program Managers.
- Michigan Department of Health and Human Services (MDHHS)coreMDHHS has partnered with biospatial since July 2018 to access and analyze Michigan EMS records. The partnership supported COVID-19 tracking, EMS call analysis during the pandemic, and informed public health decisions including delayed care campaigns.
Scale indicators10 records
Recent moves6 records
Expansion highlights7 records
biospatial competitors and assessment
Company assessmentBroad incumbents
- ImageTrend: Parent company of biospatial and the largest EMS/Fire incident data platform in the U.S., collecting 80% of U.S. incident data. Operates overlapping EMS software, ePCR, and analytics products with far broader scale.
- Health Catalyst: Enterprise healthcare data and analytics platform serving hospitals and health systems. Competes with biospatial Navigate for hospital market intelligence and analytics spend.
- Definitive Healthcare: Healthcare commercial intelligence and analytics provider for hospitals, life sciences, and government. Overlaps with biospatial's hospital market intelligence and public health analytics.
- LexisNexis Risk Solutions (Healthcare): Provides healthcare data analytics, including social determinants of health and clinical data linking. Competes with biospatial's probabilistic linking and population health analytics capabilities.
- Collective Medical (PointClickCare): Care coordination and real-time notification network across hospitals, EMS, and behavioral health. Overlaps with biospatial's patient registry and behavioral health crisis use cases.
- InterSystems HealthShare: Health informatics and interoperability platform for care coordination, analytics, and population health. Competes with biospatial on healthcare data integration and analytics.
Direct peers
- ESO Solutions: Provides EMS data software, ePCR, and analytics for fire departments, EMS agencies, and hospitals. Competes directly with biospatial in EMS data analytics and quality benchmarking.
- ZOLL Data Systems: Offers EMS billing, ePCR, and operational analytics software to ambulance services and fire agencies. Overlaps with biospatial's prehospital data analytics and quality measurement capabilities.
Emerging players
- Pulsara: Real-time care coordination platform connecting EMS, hospitals, and public health across patient events. Overlaps with biospatial's patient registry and EMS-to-hospital linking use cases.
Others
- Domo: Cloud-based analytics and BI platform used across healthcare and public sector. Adjacent to biospatial as an enabling analytics layer for healthcare data workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
biospatial social profiles
Digital presencebiospatial financial estimates
Financial estimateRevenue estimate
Valuation estimate
biospatial leadership team
Management profileNumber of profiles
Profiles6 records
biospatial funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
biospatial M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about biospatial
What does biospatial do?
biospatial combines EMS electronic patient care reports (ePCR) from thousands of EMS providers with other electronic healthcare data sources using proprietary AI and machine learning to deliver near real-time analytics, syndromic surveillance, and market intelligence. It offers a Patient Registry for cross-continuum outcome tracking, the NEMSIS Data Repository, biospatial Navigate for Hospitals, and biospatial Discover for Behavioral Health to public-sector agencies and commercial healthcare organizations.
Is biospatial a public or private company?
biospatial is a private company. It is classified as corporate owned and is currently acquired.
When was biospatial founded?
biospatial was founded in 2017. It employs 11 to 50 people.
Where is biospatial based?
biospatial is headquartered in Durham, United States, in the North America region.
How does biospatial make money?
One revenue line is on record: data Analytics Platform Subscription.
Who are biospatial's main competitors?
Broad incumbents on record are ImageTrend, Health Catalyst, Definitive Healthcare, LexisNexis Risk Solutions (Healthcare), Collective Medical (PointClickCare) and InterSystems HealthShare. Direct peers are ESO Solutions and ZOLL Data Systems. Pulsara is listed as an emerging player. Domo is listed as an others.
Does biospatial have an API?
No public API is recorded for biospatial.